medigraphic.com
SPANISH

Revista de Especialidades Médico-Quirúrgicas

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 1

<< Back Next >>

Rev Esp Med Quir 2014; 19 (1)

Ewing sarcoma/primitive neuroectodermal tumor in nasal cavity

Ordoñez GR, Ruiz MM
Full text How to cite this article

Language: Spanish
References: 8
Page: 119-121
PDF size: 680.58 Kb.


Key words:

Ewing sarcoma, primitive neuroectodermal tumor, translocation 11:22, EWS.

ABSTRACT

Ewing sarcoma / primitive neuroectodermal tumor is a rare neoplasm that belongs to the family of tumors of small round blue cells, affects men and women with a male / female ratio of 1.5:1 and have a peak incidence between 10 and 20 years. Its classic histology look with a high cellularity, composed of small, round and compact cells, giving a bluish appearance like a diffuse type lymphoma, which has served to call these also “small, round and blue cell tumors”, because stain intensely with hematoxylin. Histological diagnosis is supported by immunohistochemistry with CD99 marker and cytogenetic demonstration of the translocation 11:22. It very rarely occurs in the nasal cavity. For localized Ewing tumor, treatment usually begins with chemotherapy and if this is given at the right time, the 5-year survival can be 60 to 70%.


REFERENCES

  1. Sunil Kumar Yeshvanth, Rare case of extraskeletal Ewings sarcoma of the sinonasal tract. Journal of cancer research and therapeutics 2012;8:142-144.

  2. Naomi J Balamuth. Ewing’s sarcoma. Lancet Oncol 2010;11:184–92.

  3. Naoyoshi Hanaoka. Extraskeletal Ewing’s sarcoma in a 67-year-old man. J Orthop Sci 2011;16:250–252.

  4. Erkizan HV, Uversky VN, Toretsky JA. Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing’s sarcoma. Clin Cancer Res 2010;16:4077-83.

  5. Fellinger EJ. Immunohistochemical analysis of Ewing’s sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;139:317–25.

  6. Ambros IM. MIC2 is a specific marker for Ewing’ssarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectoderma ltumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886–93.

  7. Lajos V. Csokonai. Ewing’s sarcoma in the nasal cavity, Otolaryngol Head Neck Surg 2001;125:665-7.

  8. Saurabh Varshney,Primary extraskeletal Ewing’s sarcoma of the maxilla with intraorbital extension, Indian J Otolaryngol Head Neck Surg 2007;59:273–276.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Esp Med Quir. 2014;19